Physician profile
Samuel Bernard
NPI 1821380460
$1,645.67
in general payments reported to CMS, 2019-2025
9 companies · $1,225 in 2025
The $1,225 reported for 2025 was more than what 93% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2021: $21.58 · 2022: $18.15 · 2023: $64.01 · 2024: $208 · 2025: $1,225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,030 · Food and Beverage: $467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,030.26 |
| Food and Beverage | $466.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,234.87 | 2023-2025 | Triclip, Amplatzer Amulet |
| Novartis Pharmaceuticals Corporation | $108.78 | 2019 | |
| Getinge USA Sales, LLC | $96.13 | 2024 | Base Unit Servo-U |
| Medtronic, INC. | $59.13 | 2024 | Corevalve Evolut R, Invos |
| Pfizer INC. | $51.85 | 2022-2023 | |
| Ethicon US, LLC | $39.47 | 2024 | Stratafix, Monocryl |
| Abbvie INC. | $21.58 | 2021 | |
| Angiodynamics, INC. | $17.39 | 2025 | Alphavac |
| Amgen INC. | $16.47 | 2023 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Bernard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.